Taken together, these results indicate that CYP2J2 or its metabolite 11,12‐EET induced the nuclear accumulation of p‐Akt1 via AMPKα2 to prevent development of cardiac hypertrophy. The gene discussed is PRKAA2; the disease is cardiac hypertrophy.